Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Joshua Woolley, MD, PhD
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
University Hospital, Basel, Switzerland
Repeat Dosing of Psilocybin in Migraine Headache
Yale University
Opioid Free Anesthesia and Bariatric Surgery
Northwell Health
Drug Effects on Interpersonal Interaction
University of Chicago
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
VA Loma Linda Health Care System
A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
National Institute of Nursing Research (NINR)
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
Novartis Pharmaceuticals
A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Melt Pharmaceuticals
Pharmacokinetics of GH001 in Healthy Volunteers
GH Research Ireland Limited
Effects of Dimethyltryptamine in Healthy Subjects
University Hospital, Basel, Switzerland
The Effect of Opioid-Free Anesthesia in TMJ Surgery
Massachusetts General Hospital
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Central Institute of Mental Health, Mannheim
Effects of S-ketamine on Perioperative Opioid Consumption
Erasme University Hospital
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
Icahn School of Medicine at Mount Sinai
Precision Functional Brain Mapping in Psilocybin
Washington University School of Medicine
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Imperial College London
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
University of Colorado, Denver
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
University of California, San Diego
Ketamine Versus Fentanyl for Surgical Abortions
University of Washington
Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy
NYU Langone Health
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
Janssen-Cilag Ltd.
A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain
Antonios Likourezos
An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache
Antonios Likourezos
Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
Homeostasis Therapeutics, LLC
The Impact of Perioperative Ketamine Infusion on Surgical Recovery
Vanderbilt University Medical Center
A Study of Oral Ibogaine in Opioid Withdrawal
atai Therapeutics, Inc.
Study of CT001 in Healthy Volunteers
Cessatech A/S
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
VA Office of Research and Development
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Resilient Pharmaceuticals
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Yale University
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD
Resilient Pharmaceuticals
RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use
AppliedVR Inc.
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
New York State Psychiatric Institute
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.
IRCCS Centro Neurolesi Bonino Pulejo
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
University Hospital, Basel, Switzerland
SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Small Pharma Ltd
Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC
Centre Leon Berard
Exploring Sedation Types During Cataract Surgery
Vance Thompson Vision
Pharmacogenetics Associated With IV Ketamine
Brain and Cognition Discovery Foundation
Ketamine for Pain Control After Severe Traumatic Injury
Medical College of Wisconsin
Inpatient Single Dose Interventions for Alcohol Use Disorder
Denver Health and Hospital Authority
Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine
National Institute of Mental Health (NIMH)
Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression
Douglas Mental Health University Institute
Analgesic Efficacy of Orally Administered VTS-K for Pain Management
Antonios Likourezos
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Section for Affective Disorders; Northern Stockholm Psychiatry
Cardiac Index and General Anesthesia Without Opioid.
Centre Hospitalier de Montauban
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.